American Chemical Society--234th National Meeting. Novel targets and drug candidates. 19-23 August 2007, Boston, MA, USA.
Veryard
Claire
C
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. claire.veryard@thomson.com
D000728:Androgens / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D015507:Drugs, Investigational / Q000494:pharmacology*; D065427:Factor Xa Inhibitors; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D011374:Progesterone / Q000819:agonists / Q000037:antagonists & inhibitors
D000728:Androgens; D000962:Antimalarials; D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D065427:Factor Xa Inhibitors; D011374:Progesterone